About Us

The JaPAN consortium was initiated in 2009 by the researchers who are specialized in cancer epidemiology, bioinformatics, and gastroenterology. To date, DNA samples and lifestyle information from over 1300 pancreatic cancer patients and 1000 control subjects have been collected in multiple institutes. One major goal is to elucidate the role of inherited genetic variations in pancreatic cancer susceptibility on the basis of genome-wide association study (GWAS). To identify novel risk loci for pancreatic cancer, the JaPAN consortium conducted its own GWAS, followed by a meta-analysis of other two existing GWASs in the Japanese population (the National Cancer Center (NCC) GWAS and the BioBank Japan (BBJ) GWAS), totaling 2039 cases and 32592 control subjects, which is the largest dataset for pancreatic cancer in the Japanese population.


Steering Committee

Current research focus

Affiliated researchers